Change search criteria ↓

Search results

8 projects found matching your search criteria:

  1. 1. The impact of selective estrogen receptor modulators (SERMs) on active DNA demethylation in breast cancer cell lines

    Principal investigator: Kinga Linowiecka

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy; Wydział Farmaceutyczny

    Call: PRELUDIUM 15, Panel: NZ3

  2. 2. Uracil in DNA and aberrant DNA methylation/hydroxymethylation as a new biomarkers of multiple myeloma development? A sea…

    Principal investigator: prof. Ryszard Oliński

    Uniwersytet Mikołaja Kopernika, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy, Wydział Farmaceutyczny

    Call: OPUS 20, Panel: NZ5

  3. 3. Products of DNA demethylation and deamination pathways as new biomarkers of development and predictors of the outcome in…

    Principal investigator: dr hab. Daniel Stefan Gackowski

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy; Wydział Farmaceutyczny

    Call: OPUS 10, Panel: NZ5

  4. 4. A search for a link between epigenetical changes - active DNA demethylation and oxidative stress based on cell culture s…

    Principal investigator: prof. Ryszard Oliński

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy; Wydział Farmaceutyczny

    Call: OPUS 4, Panel: NZ1

  5. 5. A search for mechanism of anticancer properities of vitamin C; possible link between epigenetic DNA modyfications and vi…

    Principal investigator: prof. Ryszard Oliński

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy; Wydział Farmaceutyczny

    Call: OPUS 14, Panel: NZ7

  6. 6. 5-Hydroxymethylcytosine (sixth DNA base) and its putative derivative - 5-hydroxymethyluracil as a new cancer biomarkers?…

    Principal investigator: prof. Ryszard Oliński

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy; Wydział Farmaceutyczny

    Call: OPUS 5, Panel: NZ5

  7. 7. Investigation of involvement of particular TET protein family members in the generation of epigenetic DNA modyfications.

    Principal investigator: Maciej Tomasz Gawroński

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy; Wydział Farmaceutyczny

    Call: PRELUDIUM 15, Panel: NZ1

  8. 8. Oxidation products of 5-methylcytosine as a new predictive markers for respons to systemic chemotherapy of breast cancer…

    Principal investigator: dr hab. Marek Foksiński

    Uniwersytet Mikołaja Kopernika w Toruniu, Collegium Medicum im. Ludwika Rydygiera w Bydgoszczy; Wydział Farmaceutyczny

    Call: OPUS 9, Panel: NZ5

Graphic design and implementation: Jakub Piotrowski